Travere Therapeutics to Report Third Quarter 2024 Financial Results
Travere Therapeutics (NASDAQ: TVTX) has announced its plans to report third quarter 2024 financial results on Thursday, October 31, 2024, before the U.S. financial markets open. The company will host a conference call and webcast at 8:30 a.m. ET to discuss the financial results and provide a general business update.
Investors and interested parties can access the webcast and dial-in information on the Investor page of Travere's website at ir.travere.com/events-presentations. An archived version of the call will be available for 30 days on the company's website following the live webcast.
Travere Therapeutics (NASDAQ: TVTX) ha annunciato i suoi piani per comunicare i risultati finanziari del terzo trimestre 2024 giovedì 31 ottobre 2024, prima dell'apertura dei mercati finanziari statunitensi. L'azienda ospiterà una telefonata conferenza e webcast alle 8:30 a.m. ET per discutere i risultati finanziari e fornire un aggiornamento generale sulle attività.
Investitori e parti interessate possono accedere alle informazioni del webcast e della chiamata sulla pagina degli Investitori del sito web di Travere all'indirizzo ir.travere.com/events-presentations. Una versione archiviata della chiamata sarà disponibile per 30 giorni sul sito web dell'azienda dopo il webcast dal vivo.
Travere Therapeutics (NASDAQ: TVTX) ha anunciado sus planes para informar sobre los resultados financieros del tercer trimestre de 2024 el jueves 31 de octubre de 2024, antes de la apertura de los mercados financieros de EE. UU. La compañía llevará a cabo una llamada de conferencia y webcast a las 8:30 a.m. ET para discutir los resultados financieros y ofrecer una actualización general sobre el negocio.
Los inversores y partes interesadas pueden acceder a la información del webcast y la llamada en la página de Inversores del sitio web de Travere en ir.travere.com/events-presentations. Una versión archivada de la llamada estará disponible durante 30 días en el sitio web de la empresa después del webcast en vivo.
Travere Therapeutics (NASDAQ: TVTX)는 2024년 3분기 재무 결과를 2024년 10월 31일 목요일에 발표할 계획이라고 발표했습니다. 미국 금융 시장이 열리기 전에 진행됩니다. 회사는 오전 8시 30분 ET에 컨퍼런스 콜과 웹캐스트를 개최하여 재무 결과를 논의하고 일반 비즈니스 업데이트를 제공합니다.
투자자 및 관심 있는 관계자는 Travere 웹사이트의 투자자 페이지에서 ir.travere.com/events-presentations에서 웹캐스트 및 전화 접속 정보를 확인할 수 있습니다. 라이브 웹캐스트 이후, 통화의 아카이브 버전은 회사 웹사이트에서 30일 동안 이용 가능합니다.
Travere Therapeutics (NASDAQ: TVTX) a annoncé ses projets de publier les résultats financiers du troisième trimestre 2024 le jeudi 31 octobre 2024, avant l'ouverture des marchés financiers américains. L'entreprise organisera une conférence téléphonique et un webcast à 8h30 ET pour discuter des résultats financiers et donner une mise à jour générale de l'activité.
Les investisseurs et les parties intéressées peuvent accéder aux informations concernant le webcast et l'appel sur la page des investisseurs du site web de Travere à l'adresse ir.travere.com/events-presentations. Une version archivée de l'appel sera disponible pendant 30 jours sur le site de l'entreprise après le webcast en direct.
Travere Therapeutics (NASDAQ: TVTX) hat seine Pläne bekannt gegeben, die Finanzergebnisse des dritten Quartals 2024 am Donnerstag, den 31. Oktober 2024, vor der Eröffnung der US-Finanzmärkte zu veröffentlichen. Das Unternehmen wird um 8:30 Uhr ET eine Konferenzschaltung und Webcast durchführen, um die finanziellen Ergebnisse zu besprechen und ein allgemeines Geschäftsupdate zu geben.
Investoren und Interessierte können die Webcast- und Einwahlinformationen auf der Investorenseite der Travere-Website unter ir.travere.com/events-presentations einsehen. Eine archivierte Version des Anrufs wird nach dem Live-Webcast für 30 Tage auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2024 financial results on Thursday, October 31, 2024, before the open of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 8:30 a.m. ET.
The webcast and dial-in information can be accessed on the Investor page of Travere’s website at ir.travere.com/events-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
Contact Info
| Media: 888-969-7879 mediarelations@travere.com | Investors: 888-969-7879 IR@travere.com |
FAQ
When will Travere Therapeutics (TVTX) report its Q3 2024 financial results?
What time is Travere Therapeutics' (TVTX) Q3 2024 earnings call scheduled for?
Where can I access Travere Therapeutics' (TVTX) Q3 2024 earnings webcast?
How long will the archived version of Travere Therapeutics' (TVTX) Q3 2024 earnings call be available?
